ABSTRACI One hundred and four patients are reviewed who were found to have thoracic metastases arising from distant primaries. Ninety lesions were intrapulmonary and the remainder involved other thoracic structures, such as chest wall and pleura. The tissue diagnosis was established in all but eight patients. Cases were included only if review of the histology revealed that both primary and secondary tumours were identical. The chest lesion was the presenting feature of the disease in 21 patients. In the remainder, the interval between treatment of the primary and appearance of the thoracic metastasis varied from a few months to 25 years. Twelve patients had metastatic sarcoma. The remainder had metastases from the gastrointestinal tract (29), from the genitourinary tract (32), from breast primaries (18), and a miscellaneous group (13) which included five instances of malignant melanoma and metastases from adrenal, laryngeal, and thyroid primaries. The metastases were treated surgically in 47 patients. In the light of cell type, availability of nonsurgical methods of treatment, site of metastasis, and survival, an attempt is made to evaluate the place of surgery in the management of thoracic metastatic disease.
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Metastatic malignant disease involving thoracic structures is frequently not amenable to surgical treatment. However, all patients should be assessed for surgery and the lesion resected whenever possible since morbidity and mortality from thoracic surgery is low.' 2. It is important to establish a tissue diagnosis as nonsurgical methods of treatment of some tumours can result in survival of reasonable length and quality. In many cases the diagnosis is made by examination of the resected specimen. As resection does not exclude the subsequent use of nonsurgical methods of treatment, it is essential for the surgeon to work closely with his oncological colleagues.
In this paper I review 104 patients with thoracic metastatic disease, giving the results of surgery in 47 and of non-surgical methods of treatment in the remainder.
Methods
The 104 patients (0-95%) were In patients with metastases from a carcinoma the primary site was the alimentary tract in 29, the genitourinary tract in 32, the breast in 18, and various other organs in 13. In the sarcoma group the primary site was bone in five, muscle in six, and joint in one.
The surgical investigation and assessment of these patients followed the usual pattern, and note was taken of a past history of malignancy even There was no past history of malignancy in 21 patients, the chest lesion being the presenting feature of the disease (table 3). Bronchoscopy is a valuable procedure not only in assessing a pulmonary lesion for surgery but also for establishing the tissue diagnosis by biopsy in a number of patients.6 I Positive biopsy does not necessarily indicate a poor prognosis.
In five-year survivors the interval between treatment of the primary and diagnosis of the thoracic metastasis ranged from nought to seven years. In the series as a whole the best survival was seen in patients with a primary-secondary interval of between five and 10 years.
Seven of the nine five-year survivors had their metastases resected. This is the treatment of choice in all suitable instances,' 2 whether the metastasis is in the lung or some other part of the thorax. Surgery is not, however, a prerequisite for long-term survival.
Determination of the histology of the tumour and the site of the primary is essential as certain tumours respond to nonsurgical treatment. Close communication with an oncologist is therefore necessary if the most effective method of management is to be determined.
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